OneMedNet signs deal to supply de-identified clinical data to AI drug developer
ONMD•OneMedNet signs new AI drug-development data agreement
OneMedNet signed a new agreement to deliver de-identified, full-fidelity clinical real-world data to an AI-driven drug development company.
- Cohort feasibility was completed within minutes.
- Data validation was finished within a week.
- The contract was signed within three weeks of initial contact.
- Data deliveries are underway to support development and validation of AI models for drug discovery and development.
The deal highlights demand for first-party clinical datasets sourced directly from providers across OneMedNet’s iRWD network.
